Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease (Q73526348)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 1997

Language	Label	Description	Also known as
English	Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease	scientific article published on 01 July 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

coronary artery disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

B G Brown

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J Bardsley

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D Poulin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L A Hillger

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Dowdy

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

X Q Zhao

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J J Albers

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R H Knopp

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

0 references

publication date

1 July 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

80

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

111-115

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Nicotinic Acid Maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Jaundice occurring during nicotinic acid therapy for hypercholesteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Fulminant hepatic failure after ingestion of sustained-release nicotinic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Hepatic toxicity of unmodified and time-release preparations of niacin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Niacin-induced hepatitis: a potential side effect with low-dose time-release niacin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Treatment of hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Nicotinic acid-associated myopathy: a report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Niacin-induced myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Lovastatin, nicotinic acid, and rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

Nicotinic acid-induced fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900303-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9149(97)00303-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230143%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73526348&oldid=1753511100"